133 related articles for article (PubMed ID: 19893329)
1. On the mechanisms underlying 3,4-methylenedioxymethamphetamine toxicity: the dilemma of the chicken and the egg.
Puerta E; Hervias I; Aguirre N
Neuropsychobiology; 2009; 60(3-4):119-29. PubMed ID: 19893329
[TBL] [Abstract][Full Text] [Related]
2. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").
Green AR; Mechan AO; Elliott JM; O'Shea E; Colado MI
Pharmacol Rev; 2003 Sep; 55(3):463-508. PubMed ID: 12869661
[TBL] [Abstract][Full Text] [Related]
3. Loud noise enhances nigrostriatal dopamine toxicity induced by MDMA in mice.
Gesi M; Ferrucci M; Giusiani M; Lenzi P; Lazzeri G; Alessandrì MG; Salvadorini A; Fulceri F; Pellegrini A; Fornai F; Paparelli A
Microsc Res Tech; 2004 Jul; 64(4):297-303. PubMed ID: 15481049
[TBL] [Abstract][Full Text] [Related]
4. Ecstasy: are animal data consistent between species and can they translate to humans?
Easton N; Marsden CA
J Psychopharmacol; 2006 Mar; 20(2):194-210. PubMed ID: 16510478
[TBL] [Abstract][Full Text] [Related]
5. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
[TBL] [Abstract][Full Text] [Related]
6. An integrated hypothesis for the serotonergic axonal loss induced by 3,4-methylenedioxymethamphetamine.
Sprague JE; Everman SL; Nichols DE
Neurotoxicology; 1998 Jun; 19(3):427-41. PubMed ID: 9621349
[TBL] [Abstract][Full Text] [Related]
7. Neurotoxicity mechanisms of thioether ecstasy metabolites.
Capela JP; Macedo C; Branco PS; Ferreira LM; Lobo AM; Fernandes E; Remião F; Bastos ML; Dirnagl U; Meisel A; Carvalho F
Neuroscience; 2007 Jun; 146(4):1743-57. PubMed ID: 17467183
[TBL] [Abstract][Full Text] [Related]
8. Risperidone attenuates and reverses hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats.
Shioda K; Nisijima K; Yoshino T; Kuboshima K; Iwamura T; Yui K; Kato S
Neurotoxicology; 2008 Nov; 29(6):1030-6. PubMed ID: 18722468
[TBL] [Abstract][Full Text] [Related]
9. MDMA ("ecstasy") and neurotoxicity.
Mithoefer M; Jerome L; Doblin R
Science; 2003 Jun; 300(5625):1504-5; author reply 1504-5. PubMed ID: 12791964
[No Abstract] [Full Text] [Related]
10. Protective effects of minocycline on 3,4-methylenedioxymethamphetamine-induced neurotoxicity in serotonergic and dopaminergic neurons of mouse brain.
Zhang L; Shirayama Y; Shimizu E; Iyo M; Hashimoto K
Eur J Pharmacol; 2006 Aug; 544(1-3):1-9. PubMed ID: 16859675
[TBL] [Abstract][Full Text] [Related]
11. Serotonin transporter expression is not sufficient to confer cytotoxicity to 3,4-methylenedioxymethamphetamine (MDMA) in vitro.
Hayat S; Williams RJ; Rattray M
J Psychopharmacol; 2006 Mar; 20(2):257-63. PubMed ID: 16510483
[TBL] [Abstract][Full Text] [Related]
12. Early loss of dopaminergic terminals in striosomes after MDMA administration to mice.
Granado N; Escobedo I; O'Shea E; Colado I; Moratalla R
Synapse; 2008 Jan; 62(1):80-4. PubMed ID: 17960765
[TBL] [Abstract][Full Text] [Related]
13. MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.
Parrott AC
J Psychopharmacol; 2006 Mar; 20(2):147-63. PubMed ID: 16510474
[TBL] [Abstract][Full Text] [Related]
14. Association of caffeine to MDMA does not increase antinociception but potentiates adverse effects of this recreational drug.
Camarasa J; Pubill D; Escubedo E
Brain Res; 2006 Sep; 1111(1):72-82. PubMed ID: 16889759
[TBL] [Abstract][Full Text] [Related]
15. Ecstasy (3,4-methylenedioxymethamphetamine)-induced inappropriate antidiuretic hormone secretion.
Farah R; Farah R
Pediatr Emerg Care; 2008 Sep; 24(9):615-7. PubMed ID: 18797371
[TBL] [Abstract][Full Text] [Related]
16. Role of metabolites in MDMA (ecstasy)-induced nephrotoxicity: an in vitro study using rat and human renal proximal tubular cells.
Carvalho M; Hawksworth G; Milhazes N; Borges F; Monks TJ; Fernandes E; Carvalho F; Bastos ML
Arch Toxicol; 2002 Oct; 76(10):581-8. PubMed ID: 12373454
[TBL] [Abstract][Full Text] [Related]
17. Ascorbic acid prevents 3,4-methylenedioxymethamphetamine (MDMA)-induced hydroxyl radical formation and the behavioral and neurochemical consequences of the depletion of brain 5-HT.
Shankaran M; Yamamoto BK; Gudelsky GA
Synapse; 2001 Apr; 40(1):55-64. PubMed ID: 11170222
[TBL] [Abstract][Full Text] [Related]
18. Methamphetamine and methylenedioxymethamphetamine neurotoxicity: possible mechanisms of cell destruction.
Seiden LS; Sabol KE
NIDA Res Monogr; 1996; 163():251-76. PubMed ID: 8809863
[TBL] [Abstract][Full Text] [Related]
19. Effect of 3,4-methylenedioxymethamphetamine ("ecstasy") on body temperature and liver antioxidant status in mice: influence of ambient temperature.
Carvalho M; Carvalho F; Remião F; de Lourdes Pereira M; Pires-das-Neves R; de Lourdes Bastos M
Arch Toxicol; 2002 Apr; 76(3):166-72. PubMed ID: 11967622
[TBL] [Abstract][Full Text] [Related]
20. The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview.
Gouzoulis-Mayfrank E; Daumann J
J Psychopharmacol; 2006 Mar; 20(2):188-93. PubMed ID: 16510477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
